menu
    • menu

    Company profile for Cimeio Therapeutics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cimeio Therapeutics is a gene editing, cellular, and immunotherapy company pioneering Shielded-Cell & Immunotherapy Pairs to treat serious diseases. Our proprietary platform enables cells to retain full function while resisting paired immunotherapy depletion, offering groundbreaking therapeutic potential. We are dedicated to developing curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune di...
    Cimeio Therapeutics is a gene editing, cellular, and immunotherapy company pioneering Shielded-Cell & Immunotherapy Pairs to treat serious diseases. Our proprietary platform enables cells to retain full function while resisting paired immunotherapy depletion, offering groundbreaking therapeutic potential. We are dedicated to developing curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders. By leveraging advanced protein engineering and gene editing, Cimeio aims to transform patient outcomes with innovative, life-saving therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cimeio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Broadway, 14th floor Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cimeio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH
    Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH

    11 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231211209963/en

    BUSINESSWIRE
    11 Dec 2023
    Share Share
    Cimeio Therapeutics Announces Poster Presentations at ASH 2023
    Cimeio Therapeutics Announces Poster Presentations at ASH 2023

    03 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231103561414/en

    BUSINESSWIRE
    03 Nov 2023
    Share Share
    Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work
    Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work

    29 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230929975794/en

    BUSINESSWIRE
    29 Sep 2023
    Share Share
    Prime Medicine and Cimeio Therapeutics Announce Research Collaboration
    Prime Medicine and Cimeio Therapeutics Announce Research Collaboration

    22 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/22/2692866/0/en/Prime-Medicine-and-Cimeio-Therapeutics-Announce-Research-Collaboration-to-Develop-Prime-Edited-Shielded-Cell-Immunotherapy-Pairs-for-Genetic-Diseases-Acute-Myeloid-Leukemia-and-Mye.html

    GLOBENEWSWIRE
    22 Jun 2023
    Share Share
    Cimeio Therapeutics Presents Additional Proof-of-Concept Data for SCIP Platform
    Cimeio Therapeutics Presents Additional Proof-of-Concept Data for SCIP Platform

    16 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230516005051/en

    BUSINESSWIRE
    16 May 2023
    Share Share
    Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline
    Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline

    03 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221103006404/en

    BUSINESSWIRE
    03 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search